topotecan has been researched along with Adrenal Cortex Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billups, C; Davidoff, AM; Debelenko, LV; McGregor, L; Mercer, K; Morton, C; Pinto, EM; Ribeiro, RC; Rodriguez-Galindo, C; Zambetti, GP | 1 |
1 other study(ies) available for topotecan and Adrenal Cortex Cancer
Article | Year |
---|---|
Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antineoplastic Agents; Child; Disease Models, Animal; Female; Gene Expression Profiling; Humans; Male; Mice; Recurrence; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |